| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/06/2004 | EP1414861A2 Humanized antibodies against icam-1, their production and uses |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414848A2 Replikin peptides and uses thereof |
| 05/06/2004 | EP1414495A1 Anti-microbial targeting chimeric pharmaceutical |
| 05/06/2004 | EP1414494A1 Inhibitors of her3 activity |
| 05/06/2004 | EP1414493A2 Oral immunoglobulin treatment for inflammatory bowel disease |
| 05/06/2004 | EP1414492A1 Method for treating multiple myeloma |
| 05/06/2004 | EP1414491A2 Methods of inhibiting amyloid toxicity |
| 05/06/2004 | EP1414490A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 05/06/2004 | EP1414489A2 Antiallergic pharmaceutical composition |
| 05/06/2004 | EP1414488A2 Mycobacterial vaccines |
| 05/06/2004 | EP1414478A2 Inhibition of neurodegeneration |
| 05/06/2004 | EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414411A1 Pulmonary formulation comprising silicon particles |
| 05/06/2004 | EP1414305A2 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 05/06/2004 | EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0868197B1 Anti-l-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 05/06/2004 | EP0812209B1 Cochleate delivery vehicles for biologically relevant molecules |
| 05/06/2004 | EP0729509B1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/2004 | CA2510238A1 Cancer treatment using vaccine and high-dose cytokine |
| 05/06/2004 | CA2502960A1 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | CA2502696A1 Compositions and methods for treating human papillomavirus-mediated disease |
| 05/06/2004 | CA2502268A1 Methods for vaccinating against malaria |
| 05/06/2004 | CA2497909A1 Low dose methods for treating disorders in which tnf.alpha. activity is detrimental |
| 05/06/2004 | CA2482744A1 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1494588A Use of protein histidine phosphatase |
| 05/05/2004 | CN1494554A Natural HIV virus antibody |
| 05/05/2004 | CN1494553A Modified antibodies and method of use |
| 05/05/2004 | CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders |
| 05/05/2004 | CN1493302A Rabbit skin containing bioactive substance and its use |
| 05/05/2004 | CN1148577C Antibodies and SCFV immunotoxins specific to improted fire ants, and their application |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148449C Mutants of streptococcal toxin C and methods of use |
| 05/05/2004 | CN1148448C DNA for coding complete malaria antigene gp 190/MSP1, preparing process and use thereof |
| 05/05/2004 | CN1148225C Nano-level influenza virus splitting process to make subunit vaccine |
| 05/04/2004 | US6730658 Stimulation of lymphatic growth with an FLT4 ligand |
| 05/04/2004 | US6730512 Combination immunogene therapy |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730328 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 05/04/2004 | US6730307 Monoclonal antibody |
| 05/04/2004 | US6730306 Plant antigens |
| 05/04/2004 | US6730305 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730300 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 05/04/2004 | US6730296 Receptor agonists and antagonists |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2240296C Endothelial cell proliferation inhibitor and method of use |
| 05/04/2004 | CA2120137C Feline leukemia virus vaccines |
| 05/04/2004 | CA2080226C Cd4-gamma2 and cd4-igg2 chimeras |
| 04/29/2004 | WO2004036221A2 Compositions and methods for diagnosing and treating autoimmune disease |
| 04/29/2004 | WO2004035795A1 Vector for anti-hpv vaccine and transformed microorganism by the vector |
| 04/29/2004 | WO2004035793A1 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses thereof |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035769A1 Improved immunotherapy |
| 04/29/2004 | WO2004035748A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | WO2004035618A2 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 04/29/2004 | WO2004035609A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 04/29/2004 | WO2004035602A2 Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004035088A1 Therapeutics/diagnostics for brain tumor |
| 04/29/2004 | WO2004035087A1 Method for decreasing depression by inhibiting the activity of n-type calcium channel |
| 04/29/2004 | WO2004035085A1 Gene vaccine |
| 04/29/2004 | WO2004035084A2 Formulation of glutarmic acid decarboxylase (gad65) and serum albumin |
| 04/29/2004 | WO2004035028A1 Method for producing the microcapsulated form of a live viral vaccine |
| 04/29/2004 | WO2004035021A2 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/29/2004 | WO2004035007A2 Transmucosal administration of aggregated antigens |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004035003A2 Therapeutic adjuvant |
| 04/29/2004 | WO2004034995A2 Methods and reagents for inducing immunity |
| 04/29/2004 | WO2004034971A2 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof |
| 04/29/2004 | WO2004034966A2 Substances for preventing and treating autoimmune diseases |
| 04/29/2004 | WO2004034956A2 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 04/29/2004 | WO2004034789A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 04/29/2004 | WO2004022092A3 Flagellin peptides as adjuvants for vaccines |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004007770A3 Method for diagnosis of intestinal-type gastric tumors |
| 04/29/2004 | WO2003095487A3 Immunogenic cd1 complexes |
| 04/29/2004 | WO2003087408A3 Schizophrenia associated genes |
| 04/29/2004 | WO2003075840A3 Human antibodies specific to kdr and uses thereof |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003053473A3 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 04/29/2004 | WO2003051305A3 Innate immune system-directed vaccines |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2003009812A3 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 04/29/2004 | WO2003007986A8 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2003000204A8 Multivalent mycoplasma bacterin |
| 04/29/2004 | WO2002090510A9 Regulating immine responses using dendritic cells |
| 04/29/2004 | WO2002088380A9 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 04/29/2004 | WO2002070748A3 Response of dendritic cells to a diverse set of pathogens |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 04/29/2004 | WO2002043651A8 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |